Proteins have been widely used in the biomedical field because of their well-defined architecture,accurate molecular weight,excellent biocompatibility and biodegradability,and easy-to-functionalization.Inspired by the...Proteins have been widely used in the biomedical field because of their well-defined architecture,accurate molecular weight,excellent biocompatibility and biodegradability,and easy-to-functionalization.Inspired by the wisdom of nature,increasing proteins/peptides that possess self-assembling capabilities have been explored and designed to generate nanoassemblies with unique structure and function,including spatially organized conformation,passive and active targeting,stimuli-responsiveness,and high stability.These characteristics make protein/peptide-based nanoassembly an ideal platform for drug delivery and vaccine development.In this review,we focus on recent advances in subsistent protein/peptide-based nanoassemblies,including protein nanocages,virus-like particles,self-assemblable natural proteins,and self-assemblable artificial peptides.The origin and characteristics of various protein/peptide-based assemblies and their applications in drug delivery and vaccine development are summarized.In the end,the prospects and challenges are discussed for the further development of protein/peptide-based nanoassemblies.展开更多
Despite recent advances in melanoma treatment through the use of antibody immunotherapy,the clinical benefit remains restricted by its inefficient infiltration and immunosuppression within the tumor microenvironment(T...Despite recent advances in melanoma treatment through the use of antibody immunotherapy,the clinical benefit remains restricted by its inefficient infiltration and immunosuppression within the tumor microenvironment(TME).In addition,immunerelated adverse events(irAEs)have often occurred due to the off-target binding of therapeutic drugs to normal tissues after systematic administration.Herein,we constructed an integrated and cascaded drug delivery system for the treatment of melanoma.In addition to blocking the programmed cell death protein 1 or its ligand(PD-1/PD-L1)axis,the PD-L1 targeting peptide(FE)with spherical micelle self-assembly characteristics could also effectively encapsulate the immune adjuvant resiquimod(R848),and form a complete nano drug.FE^(R)was further integrated into tumor-responsive microneedles(MNs)to establish FE^(R)@MN and could reach the cascaded functions.FE^(R)could be sustainedly released from the MN system and disassemble into monomers,achieving PD-1/PD-L1 axis blockade whilst reprogramming the immunosuppressive TME.Notably,FE^(R)@MN permits the controllable release and retention enhancement of the targeting peptide in the TME,thus causing prolonged PD-L1 blockade effect.It is demonstrated that this synergistic treatment could efficiently inhibit melanoma growth,providing a new strategy for the combination treatment of melanoma.展开更多
基金the National Key Research and Development Program of China(No.2019YFA0905200)the National Natural Science Foundation of China(No.82072045)the Natural Science Foundation of Jiangsu Province of China for Excellent Young Scholars(No.BK20190084).
文摘Proteins have been widely used in the biomedical field because of their well-defined architecture,accurate molecular weight,excellent biocompatibility and biodegradability,and easy-to-functionalization.Inspired by the wisdom of nature,increasing proteins/peptides that possess self-assembling capabilities have been explored and designed to generate nanoassemblies with unique structure and function,including spatially organized conformation,passive and active targeting,stimuli-responsiveness,and high stability.These characteristics make protein/peptide-based nanoassembly an ideal platform for drug delivery and vaccine development.In this review,we focus on recent advances in subsistent protein/peptide-based nanoassemblies,including protein nanocages,virus-like particles,self-assemblable natural proteins,and self-assemblable artificial peptides.The origin and characteristics of various protein/peptide-based assemblies and their applications in drug delivery and vaccine development are summarized.In the end,the prospects and challenges are discussed for the further development of protein/peptide-based nanoassemblies.
基金supported by the National Natural Science Foundation of China(No.22074006)Beijing Natural Science Foundation(No.2222029)Beijing Institute of Technology Research Fund Program for Young Scholars.
文摘Despite recent advances in melanoma treatment through the use of antibody immunotherapy,the clinical benefit remains restricted by its inefficient infiltration and immunosuppression within the tumor microenvironment(TME).In addition,immunerelated adverse events(irAEs)have often occurred due to the off-target binding of therapeutic drugs to normal tissues after systematic administration.Herein,we constructed an integrated and cascaded drug delivery system for the treatment of melanoma.In addition to blocking the programmed cell death protein 1 or its ligand(PD-1/PD-L1)axis,the PD-L1 targeting peptide(FE)with spherical micelle self-assembly characteristics could also effectively encapsulate the immune adjuvant resiquimod(R848),and form a complete nano drug.FE^(R)was further integrated into tumor-responsive microneedles(MNs)to establish FE^(R)@MN and could reach the cascaded functions.FE^(R)could be sustainedly released from the MN system and disassemble into monomers,achieving PD-1/PD-L1 axis blockade whilst reprogramming the immunosuppressive TME.Notably,FE^(R)@MN permits the controllable release and retention enhancement of the targeting peptide in the TME,thus causing prolonged PD-L1 blockade effect.It is demonstrated that this synergistic treatment could efficiently inhibit melanoma growth,providing a new strategy for the combination treatment of melanoma.
